(2R,3S,4R,5S,6S)-2-((5-bromo-4-chloro-1H-indol-3-yl)oxy)-6-methyltetrahydro-2H-pyran-3,4,5-triol, 98%, 250mg

4-Hydroxy-2-(trifluoromethyl)benzonitrile, 98.0%, 5g

1-(tert-Butoxycarbonyl)-4-piperidinecarboxylic Acid>96.0%(GC)(T)5g

[1-(2-methoxyethyl)pyrrolidin-3-yl]methanol, 95.0%, 1g

6-Phenylpyridin-3-amine, 95.0%, 250mg

Nitrato di cerio (III) esaidrato, minimo 99,5%, pa, 100 g, confezione in plastica.

5-(chloromethyl)-2-methanesulfonyl-1-(3-methylbutyl)-1H-imidazole, 95.0%, 10g

rel-(3R,4R)-1-(tert-Butoxycarbonyl)-3-hydroxypiperidine-4-carboxylic acid, 98%, 10g

(S)-1-amino-3-methyl-4,5-dihydro-1H-benzo[d]azepin-2(3H)-one (2R,3R)-2,3-bis(4-methylbenzoyloxy)succinate, 98%, 1g

(4-isothiocyanatophenyl)(2-methylphenyl)amine, 95.0%, 10g

Methyl 4-(hydroxymethyl)benzoate, 99.00%, 100g

N-Methyl-O-(10H-phenothiazine-10-carbonyl)hydroxylamine hydrochloride, 95%, 250mg

5-oxo-5-phenylvaleric acid, 97.0%, 25g